Stock ALNY ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-01 EDT 		5-day change 1st Jan Change
150 USD +4.18% Intraday chart for Alnylam Pharmaceuticals, Inc. +4.28% -21.66%
04-30 Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of Their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in Additional Latam and APAC Markets Including Australia CI
04-08 Sector Update: Health Care Stocks Flat to Higher Premarket Monday MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ALNYLAM PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
+4.18%+4.28%-21.66%-25.71%+80.61% 18.96B
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. Charts Alnylam Pharmaceuticals, Inc.
  5. Comparison Chart